Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
April 2, 2013
Patent Application Number
12768173
Date Filed
April 27, 2010
Patent Citations Received
Patent Primary Examiner
Patent abstract
Compounds, compositions and methods are provided for treating cancer and inflammatory diseases, and for releasing cells such as stem cells (e.g., bone marrow progenitor cells) into circulating blood and enhancing retention of the cells in the blood. More specifically, heterobifunctional compounds that inhibit both E-selectins and CXCR4 chemokine receptors are described.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.